MORRIS PLAINS, N.J., Oct. 30, 2007 (PRIME NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that Gerard G. Gorman, Senior Vice President of Finance and Business Development, and Chief Financial Officer, will be presenting at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference to be held at the New York Palace Hotel from November 5 - 7, 2007.
